CC09
EDSS: To Walk or Not to Walk? Assessing the Reliability of Patients to Self-Report Their Ambulation Distance Prior to Measuring Actual Distance Walked

Friday, May 29, 2015
Griffin Hall
Jacob (Jake) Reznik, student , Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada
Marcie Weiss, student , Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada
Kayla McGowan, B.Sci. , Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada
Calvin Mok, B.Sci. , Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada
Tara Martin, B.Sci. , Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada
Jill R Nelson, RN BScN MSCN , Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada
Elliott Weiss, MD, FRCPS(C) , Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada
Galina Vorobeychik, MD, FRCPS(C), CMSC , Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada
PDF


Background: The most commonly used disability scale in patients with Multiple Sclerosis is EDSS (Extended Disability Scale Score), which was developed by J.F.Kurtzke in 1983. EDSS scores 5.0 to 8.0 are predominately defined by impairment in ambulation. It is common in clinical practice to substitute walking test with self-reported patient information on ability to walk, especially for patients who are able to walk greater than 100 m. There is little information published about reliability of using such approach and factors affecting it.

Objectives: (1) To establish correlation between subjective walk (SW, self-reported patient ability to walk) and objectively walked distance under supervision of trained provider (OW). (2) To analyze impact of different cognitive factors on this correlation.

Methods: We randomly selected 30 MS patients (20 females, 10 males with average age 47±7 years) with varying degrees of disability. Per clinical practice, each patient was assessed for: depression, anxiety, fatigue, cognition, and administered the 25 foot walk as well as reported SW and Patient Determined Disease Steps (PDDS) prior to walking up to 500 m under supervision of trained provider (OW).

Results: We excluded three patients from 30, who were unable to estimate SW but able to walk 100 m - 400 m. Among 18 patients with SW of 500 m or more, 3 (17%) were not able to walk further than 300 m. The PDDS was between 2 and 3 for these patients. Among 9 patients with SW less than 500 m, 7 patients (78%) were able to walk 100 m greater than they reported, which affects EDSS. Of these 7 patients, PDDS was between 3 and 5 and none had severe cognitive impairment, depression, anxiety or fatigue. A detailed analysis of data will be provided in the poster.

Conclusions: Patient self-reported ability to walk differs from actually measured in some patients (17%) who have reasonably preserved ambulation, and in majority of the patients (78%) with limited ambulation. This data reinforces proper technique of measuring ambulation with trained supervised provider to obtain accurate EDSS scores. We were unable to determine impact of depression, anxiety, fatigue, cognition, 25 ft. walk and reported SW and PDDS on self-reported bias. Additional studies with larger numbers of patients will be needed to confirm our results and to analyze impact of above mentioned factors.